Cargando…

SAT-200 Therapeutic Targeting of Functional MicroRNA Expression by Curcumin in Human Endometrial Stromal Cells

Endometriosis is a chronic gynecological inflammatory disorder in which immune system dysregulation is thought to play a role in its initiation and progression. Current agency-approved hormonal therapies, including synthetic progestins, GnRH-agonists, and danazol are often of limited efficacy and co...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Indrajit, Banerjee, Saswati, Driss, Adel, Xu, Wei, Nezhat, Ceana, Sidell, Neil, Taylor, Robert, Thompson, Winston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551847/
http://dx.doi.org/10.1210/js.2019-SAT-200
_version_ 1783424467747209216
author Chowdhury, Indrajit
Banerjee, Saswati
Driss, Adel
Xu, Wei
Nezhat, Ceana
Sidell, Neil
Taylor, Robert
Thompson, Winston
author_facet Chowdhury, Indrajit
Banerjee, Saswati
Driss, Adel
Xu, Wei
Nezhat, Ceana
Sidell, Neil
Taylor, Robert
Thompson, Winston
author_sort Chowdhury, Indrajit
collection PubMed
description Endometriosis is a chronic gynecological inflammatory disorder in which immune system dysregulation is thought to play a role in its initiation and progression. Current agency-approved hormonal therapies, including synthetic progestins, GnRH-agonists, and danazol are often of limited efficacy and counterproductive to fertility, and cause systemic side effects due to suppression of endogenous steroid hormone production. Our recent publication (PMID: 30259980) suggests that curcumin (diferuloylmethane, CUR), an anti-inflammatory folk medicine in Asian countries, has therapeutic potential to reduce inflammation associated with endometriosis. Therefore, in the current studies we examined the effects of CUR at different doses over a time course in the regulation of proinflammatory and proangiogenic microRNAs (miRNAs) in primary cultures of normal endometrial stromal cells (NESC) and cells derived from eutopic endometrium of endometriosis subjects (EESC). miRNAs are non-coding RNAs that regulate protein translation and have been shown to be involved in the pathogenesis of endometriosis. Using NanoString nCounter-based assays and semi-quantitative RT-PCR we have identified levels of several proinflammatory and proangiogenic miRNAs (including has-miR-196b-5p, has-miR-199a-5p, has-miR-21-5p) that are higher in EESC compared to NESC. EESC and NESC treatment with CUR significantly reduced expression of proinflammatory and proangiogenic miRNAs in a dose- and time-dependent manner. Notably, CUR significantly decreased phosphorylation of the AKT, ERK and prohibitin signaling pathways. These findings demonstrate higher proinflammatory and proangiogenic miRNA production in EESC compared to NESC under basal conditions, and suggest that by suppressing these factors, CUR has the therapeutic potential to reduce inflammation associated with endometriosis. Nothing to Disclose: IC; SB; AD; WX; CN; NS, RNT, WET. Sources of Research Support: This study was supported in part by National Institutes of Health Grants 1SC3 GM113751, U01 HD66439, 1R01HD057235, U54 CA118948, HD41749, S21MD000101 and G12-MD007602. This investigation was conducted in a facility constructed with support from Research Facilities Improvement Grant #C06 RR018386 from NIH/NCRR.
format Online
Article
Text
id pubmed-6551847
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65518472019-06-13 SAT-200 Therapeutic Targeting of Functional MicroRNA Expression by Curcumin in Human Endometrial Stromal Cells Chowdhury, Indrajit Banerjee, Saswati Driss, Adel Xu, Wei Nezhat, Ceana Sidell, Neil Taylor, Robert Thompson, Winston J Endocr Soc Reproductive Endocrinology Endometriosis is a chronic gynecological inflammatory disorder in which immune system dysregulation is thought to play a role in its initiation and progression. Current agency-approved hormonal therapies, including synthetic progestins, GnRH-agonists, and danazol are often of limited efficacy and counterproductive to fertility, and cause systemic side effects due to suppression of endogenous steroid hormone production. Our recent publication (PMID: 30259980) suggests that curcumin (diferuloylmethane, CUR), an anti-inflammatory folk medicine in Asian countries, has therapeutic potential to reduce inflammation associated with endometriosis. Therefore, in the current studies we examined the effects of CUR at different doses over a time course in the regulation of proinflammatory and proangiogenic microRNAs (miRNAs) in primary cultures of normal endometrial stromal cells (NESC) and cells derived from eutopic endometrium of endometriosis subjects (EESC). miRNAs are non-coding RNAs that regulate protein translation and have been shown to be involved in the pathogenesis of endometriosis. Using NanoString nCounter-based assays and semi-quantitative RT-PCR we have identified levels of several proinflammatory and proangiogenic miRNAs (including has-miR-196b-5p, has-miR-199a-5p, has-miR-21-5p) that are higher in EESC compared to NESC. EESC and NESC treatment with CUR significantly reduced expression of proinflammatory and proangiogenic miRNAs in a dose- and time-dependent manner. Notably, CUR significantly decreased phosphorylation of the AKT, ERK and prohibitin signaling pathways. These findings demonstrate higher proinflammatory and proangiogenic miRNA production in EESC compared to NESC under basal conditions, and suggest that by suppressing these factors, CUR has the therapeutic potential to reduce inflammation associated with endometriosis. Nothing to Disclose: IC; SB; AD; WX; CN; NS, RNT, WET. Sources of Research Support: This study was supported in part by National Institutes of Health Grants 1SC3 GM113751, U01 HD66439, 1R01HD057235, U54 CA118948, HD41749, S21MD000101 and G12-MD007602. This investigation was conducted in a facility constructed with support from Research Facilities Improvement Grant #C06 RR018386 from NIH/NCRR. Endocrine Society 2019-04-30 /pmc/articles/PMC6551847/ http://dx.doi.org/10.1210/js.2019-SAT-200 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Reproductive Endocrinology
Chowdhury, Indrajit
Banerjee, Saswati
Driss, Adel
Xu, Wei
Nezhat, Ceana
Sidell, Neil
Taylor, Robert
Thompson, Winston
SAT-200 Therapeutic Targeting of Functional MicroRNA Expression by Curcumin in Human Endometrial Stromal Cells
title SAT-200 Therapeutic Targeting of Functional MicroRNA Expression by Curcumin in Human Endometrial Stromal Cells
title_full SAT-200 Therapeutic Targeting of Functional MicroRNA Expression by Curcumin in Human Endometrial Stromal Cells
title_fullStr SAT-200 Therapeutic Targeting of Functional MicroRNA Expression by Curcumin in Human Endometrial Stromal Cells
title_full_unstemmed SAT-200 Therapeutic Targeting of Functional MicroRNA Expression by Curcumin in Human Endometrial Stromal Cells
title_short SAT-200 Therapeutic Targeting of Functional MicroRNA Expression by Curcumin in Human Endometrial Stromal Cells
title_sort sat-200 therapeutic targeting of functional microrna expression by curcumin in human endometrial stromal cells
topic Reproductive Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551847/
http://dx.doi.org/10.1210/js.2019-SAT-200
work_keys_str_mv AT chowdhuryindrajit sat200therapeutictargetingoffunctionalmicrornaexpressionbycurcumininhumanendometrialstromalcells
AT banerjeesaswati sat200therapeutictargetingoffunctionalmicrornaexpressionbycurcumininhumanendometrialstromalcells
AT drissadel sat200therapeutictargetingoffunctionalmicrornaexpressionbycurcumininhumanendometrialstromalcells
AT xuwei sat200therapeutictargetingoffunctionalmicrornaexpressionbycurcumininhumanendometrialstromalcells
AT nezhatceana sat200therapeutictargetingoffunctionalmicrornaexpressionbycurcumininhumanendometrialstromalcells
AT sidellneil sat200therapeutictargetingoffunctionalmicrornaexpressionbycurcumininhumanendometrialstromalcells
AT taylorrobert sat200therapeutictargetingoffunctionalmicrornaexpressionbycurcumininhumanendometrialstromalcells
AT thompsonwinston sat200therapeutictargetingoffunctionalmicrornaexpressionbycurcumininhumanendometrialstromalcells